NCT00252330View on ClinicalTrials.gov

Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

476

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions
Major Depressive Disorder
Interventions
DRUG

SR58611A

Trial Locations (2)

08807

Sanofi-Aventis Administrative Office, Bridgewater

Unknown

Sanofi-Aventis Administrative Office, Laval

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00252330 - Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder | Biotech Hunter | Biotech Hunter